{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:17:46Z","timestamp":1776705466671,"version":"3.51.2"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Multisystem inflammatory syndrome in children (MIS-C) rarely involves delayed giant coronary aneurysms, multiple readmissions or occurrence after COVID-19 vaccination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We describe a child with all 3 of these unusual features. We discuss his clinical presentation, medical management, review of the current literature and CDC guidance recommendations regarding further vaccinations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A 5-year-old boy had onset of MIS-C symptoms 55 days after COVID-19 illness and 15 days after receiving his first BNT162b2 COVID-19 vaccination. He was admitted 3 times for MIS-C, and twice after his steroid dose was tapered. On his initial admission, he was given intravenous immunoglobulin and steroids. During his second admission, new, moderate coronary dilation was noted, and he was treated with intravenous immunoglobulin and steroids. At his last admission, worsening coronary dilation was noted, and he was treated with infliximab and steroids. During follow-up, he had improvement in his coronary artery dilatation. However, his inflammatory markers increased after steroid wean, and his steroid taper was further extended, after which time his inflammatory markers improved. This is the only such reported case of a patient who was admitted 3 times for MIS-C complications after COVID-19 vaccination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>MIS-C rarely involves delayed giant coronary aneurysms, multiple readmissions, or occurrence after COVID-19 vaccination. Whether our patient\u2019s COVID-19 vaccine 6 weeks after COVID-19 illness contributed to his MIS-C is unknown. After consultation with the CDC-funded Clinical Immunization Safety Assessment Project, the patient\u2019s care team decided against further COVID-19 vaccination until at least 3 months post normalization of inflammatory markers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003801","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:42:55Z","timestamp":1675374175000},"page":"e64-e69","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Multiple MIS-C Readmissions and Giant Coronary Aneurysm After COVID-19 Illness and Vaccination: A Case Report"],"prefix":"10.1097","volume":"42","author":[{"given":"Khadija","family":"Haq","sequence":"first","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta"},{"name":"Department of Pediatrics, Morehouse School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Gloria","family":"Anyalechi","sequence":"additional","affiliation":[{"name":"Clinical Immunization Safety Assessment, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth P.","family":"Schlaudecker","sequence":"additional","affiliation":[{"name":"Cincinnati Children\u2019s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"McKay","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kamidani","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta"},{"name":"Clinical Immunization Safety Assessment, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia K.","family":"Manos","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2243-8367","authenticated-orcid":false,"given":"Matthew E.","family":"Oster","sequence":"additional","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta"},{"name":"Clinical Immunization Safety Assessment, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic.","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamapediatrics.2021.0630","article-title":"Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic.","volume":"175","author":"Belay","year":"2021","journal-title":"JAMA Pediatr"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11886-021-01602-3","article-title":"Cardiac manifestations of multisystem inflammatory syndrome in children (MIS-C) following COVID-19.","volume":"23","author":"Wu","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jaccas.2021.06.043","article-title":"Giant coronary aneurysms in multisystem inflammatory syndrome in children associated with SARS-CoV-2 Infection.","volume":"3","author":"Villacis-Nunez","year":"2021","journal-title":"JACC Case Rep"},{"key":"R5-20250614","first-page":"31","article-title":"Delayed coronary dilation with multisystem inflammatory syndrome in children.","volume":"61","author":"Nelson","year":"2022","journal-title":"CASE (Phila)"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jamapediatrics.2022.0292","article-title":"Short-term outcomes of corticosteroid monotherapy in multisystem inflammatory syndrome in children.","volume":"176","author":"Villacis-Nunez","year":"2022","journal-title":"JAMA Pediatr"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"100393","DOI":"10.1016\/j.lanepe.2022.100393","article-title":"Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study.","volume":"17","author":"Ouldali","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S2352-4642(22)00028-1","article-title":"Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.","volume":"6","author":"Yousaf","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"e2021055956","DOI":"10.1542\/peds.2021-055956","article-title":"Multisystem inflammatory syndrome following SARS-CoV-2 vaccination in two children.","volume":"150","author":"Karatzios","year":"2022","journal-title":"Pediatrics"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapediatrics.2022.2206","article-title":"Risk and phenotype of multisystem inflammatory syndrome in vaccinated and unvaccinated Danish children before and during the omicron wave.","volume":"176","author":"Holm","year":"2022","journal-title":"JAMA Pediatr"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"e224750","DOI":"10.1001\/jamanetworkopen.2022.4750","article-title":"Outcomes after SARS-CoV-2 vaccination among children with a history of multisystem inflammatory syndrome.","volume":"5","author":"Wisniewski","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpeds.2022.05.028","article-title":"Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey.","volume":"248","author":"Hoste","year":"2022","journal-title":"J Pediatr"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association.","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"R15-20250614","first-page":"e201730","article-title":"Frequently asked questions regarding treatment of Kawasaki disease.","volume":"2017","author":"Burns","year":"2017","journal-title":"Glob Cardiol Sci Pract"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/rheumatology\/keaa365","article-title":"Successful treatment of coronary artery aneurysm with infliximab in a Behcet\u2019s disease patient.","volume":"60","author":"Satis","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/art.42062","article-title":"American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS-COV-2 and hyperinflammation in pediatric COVID-19: version 3.","volume":"74","author":"Henderson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jama.2021.0694","article-title":"Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children.","volume":"325","author":"Ouldali","year":"2021","journal-title":"JAMA"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15585\/mmwr.mm7102e1","article-title":"Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12\u201318 years\u2014United States, July\u2013December 2021.","volume":"71","author":"Zambrano","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 1","key":"R22-20250614","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1542\/peds.2010-1722J","article-title":"Understanding the role of human variation in vaccine adverse events: the clinical immunization safety assessment network.","volume":"127","author":"LaRussa","year":"2011","journal-title":"Pediatrics"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:04:07Z","timestamp":1749945847000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003801","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,15]]}}}